Moves Closer to Development Completion of Its Novel Point-of-Care Diagnostic Platform ANN ARBOR, Mich., June 16, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (“Zomedica” or the “Company”) (NYSE American: ZOM), a veterinary diagnostic company, announced that it has appointed Robert Cohen, formerly of EmboMedics, Inc., as its Interim Chief Executive… Read More..

VAN NUYS, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Eco Innovation Group, Inc. ("ECOX" or the "Company") (OTC: ECOX), an innovative company aggregating investments in new technologies that are environmental friendly, promote green energy and are socially responsible, announced today the Exclusive Global Licensing Agreement with the Bellagio IP Trust… Read More..

Exicure, Inc. (NASDAQ: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, announced today the dosing of the first patient enrolled in the Phase 2 dose expansion stage of the cavrotolimod (AST-008) Phase 1b/2 clinical trial (ClinicalTrials.gov identifier: NCT03684785). "We believe this milestone marks… Read More..